rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TVGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement

      Up to $28.6 million in borrowing capacity through May 2029 WARREN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), a healthcare company focused on combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, has extended the end of the borrowing period under its existing loan agreement with The Patel Family, LLP from May 2027 to May 2029. The facility permits borrow

      Nov 9Yahoo FinanceTVGN
      Tevogen Bio Signs Letter of Intent to Evaluate HRK Healthcare Acquisition
      Oct 8Yahoo FinanceTVGN
      Tevogen Bio Regains Full Nasdaq Listing Compliance

      Tipranks Press Release.

      Oct 1The Globe and MailTVGN
      Tevogen Bio Holdings Regains Compliance With Nasdaq Minimum Market Value Requirement

      Tevogen Bio Holdings (TVGN) said Wednesday it received written notice from Nasdaq on Sept. 29 confir

      Sep 30Yahoo FinanceTVGN
      Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
      Sep 30Yahoo FinanceTVGN
      Tevogen Bio regains Nasdaq listing compliance status

      Detailed price information for Tevogen Inc (TVGN-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailTVGN
      Tevogen regains Nasdaq compliance with minimum market value requirement
      Sep 10Investing.comTVGN

      This is the newest page. Registered accounts read further back.